Literature DB >> 26067458

Sex- and age-based variation in transfusion practices among patients undergoing major surgery.

Javier Valero-Elizondo1, Gaya Spolverato1, Yuhree Kim1, Doris Wagner1, Aslam Ejaz1, Steven M Frank1, Timothy M Pawlik2.   

Abstract

BACKGROUND: Data on hemoglobin (Hb) threshold levels for "appropriate" packed red blood cell (PRBC) transfusions have not taken into account patient-specific variables such as sex and age. We sought to define differences in perioperative transfusion practices based on patient sex and age among patients undergoing complex gastrointestinal (GI) and cardiothoracic-vascular (CT-V) surgical procedures.
METHODS: All patients undergoing any major GI or CT-V procedures between January 2010 and April 2014 at the Johns Hopkins Hospital were identified. Data on sex, age, as well as other clinicopathologic and procedures were collected and analyzed relative to transfusion practices (restrictive: transfusion at blood Hb < 7 vs liberal transfusion at Hb ≥ 7 g/dL).
RESULTS: Among the 10,772 patients included in the study cohort, 4,689 (44.0%) were transfused with ≥ 1 PRBC. Median preoperative Hb was lower among women (12.3 vs 13.4 g/dL in men) and the aged (<65 years, 13.1 vs ≥ 65 years, 12.7 g/dL) patients (both P < .05). On adjusted analysis, male sex (odds ratio [OR], 1.13; 95% CI, 1.02-1.26; P = .03) and age ≥ 65 (OR, 1.77; 95% CI, 1.35-2.33; P < .001) were associated independently with an increased odds of receipt of ≥ 1 PRBC. Although sex did not seem to impact transfusion strategy, patient age did impact the relative trigger used by providers for a transfusion. Specifically, patients 65-74 years (OR, 2.87; 95% CI, 1.93-4.26) and those ≥ 74 years (OR, 3.42; 95% CI, 2.28-5.14) were at a much greater odds of being transfused liberally compared with patients <65 years old (both P < .05). The proportion of patients who had a potentially avoidable transfusion (ie, both trigger ≥ 7 and target ≥ 9 g/dL) was greater among aged patients (50%) compared with nonaged patients (41%; P < .001). Of note, a restrictive transfusion strategy did not increase the risk of overall morbidity among women (OR, 0.76; 95% CI, 0.59-0.99; P = .04) or aged (OR, 1.13; 95% CI, 0.87-1.47; P = .37) patients.
CONCLUSION: Sex and age were associated with receipt of transfusion and, in the case of older patients, transfusion strategy. Given the lack of evidence to support a higher Hb level in older patients, emphasis should be placed on aligning transfusion practices with current evidence to employ a more restrictive transfusion strategy to decrease overuse of blood resources.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26067458     DOI: 10.1016/j.surg.2015.04.030

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  3 in total

1.  Red Blood Cell Transfusions in Greece: Results of a Survey of Red Blood Cell Use in 2013.

Authors:  Serena Valsami; Elisavet Grouzi; Abraham Pouliakis; Leontini Fountoulaki-Paparisos; Elias Kyriakou; Maria Gavalaki; Elias Markopoulos; Ekaterini Kontopanou; Ioannis Tsolakis; Argyrios Tsantes; Alexandra Tsoka; Anastasia Livada; Vassiliki Rekari; Niki Vgontza; Dimitra Agoritsa; Marianna Politou; Stavros Nousis; Aspasia Argyrou; Ekaterini Manaka; Maria Baka; Maria Mouratidou; Stavroula Tsitlakidou; Konstantinos Malekas; Dimitrios Maltezo; Paraskevi Papadopoulou; Vassiliki Pournara; Ageliki Tirogala; Emmanouil Lysikatos; Sousanna Pefani; Konstantinos Stamoulis
Journal:  Turk J Haematol       Date:  2016-11-22       Impact factor: 1.831

2.  Characteristics of Recipients of Red Blood Cell Concentrates in a German Federal State.

Authors:  Linda Schönborn; Kerstin Weitmann; Andreas Greinacher; Wolfgang Hoffmann
Journal:  Transfus Med Hemother       Date:  2020-09-22       Impact factor: 3.747

3.  Impact of gender parity on preoperative anaemia prevalence and Patient Blood Management practice.

Authors:  Ivo Beverina; Alessandro Aloni; Bruno Brando
Journal:  Blood Transfus       Date:  2020-09-17       Impact factor: 3.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.